Fagron 将来の成長

ENXTBR:FAGR - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	973	112	132	167	5
12/31/2025	910	98	122	154	5
12/31/2024	853	84	91	126	5
6/30/2024	821	78	85	123	N/A
3/31/2024	792	74	86	124	N/A
12/31/2023	763	71	86	125	N/A
9/30/2023	745	69	84	119	N/A
6/30/2023	727	67	81	114	N/A
3/31/2023	705	69	86	112	N/A
12/31/2022	684	70	91	109	N/A
9/30/2022	655	70	79	98	N/A
6/30/2022	626	69	67	86	N/A
3/31/2022	600	65	63	82	N/A
12/31/2021	574	61	58	78	N/A
9/30/2021	564	58	69	88	N/A
6/30/2021	554	55	79	97	N/A
3/31/2021	555	57	77	95	N/A
12/31/2020	556	60	75	93	N/A
9/30/2020	557	60	60	80	N/A
6/30/2020	558	60	45	67	N/A
3/31/2020	546	58	50	72	N/A
12/31/2019	535	55	55	77	N/A
6/30/2019	496	51	54	76	N/A
3/31/2019	484	47	56	75	N/A
12/31/2018	472	43	58	73	N/A
6/30/2018	444	45	60	69	N/A
3/31/2018	439	46	N/A	77	N/A
12/31/2017	434	47	N/A	84	N/A
9/30/2017	433	16	N/A	N/A	N/A
6/30/2017	432	-14	N/A	101	N/A
3/31/2017	428	-15	N/A	113	N/A
12/31/2016	422	-19	N/A	68	N/A
9/30/2016	421	-25	N/A	60	N/A
6/30/2016	421	-31	N/A	53	N/A
3/31/2016	474	-203	N/A	73	N/A
12/31/2015	428	-25	N/A	73	N/A
9/30/2015	441	8	N/A	83	N/A
6/30/2015	455	41	N/A	92	N/A
3/31/2015	445	38	N/A	58	N/A
12/31/2014	447	43	N/A	102	N/A
9/30/2014	418	46	N/A	N/A	N/A
6/30/2014	389	49	N/A	85	N/A
3/31/2014	366	46	N/A	74	N/A
12/31/2013	343	42	N/A	63	N/A

アナリストによる今後の成長予測

収入対貯蓄率: FAGRの予測収益成長率 (年間14.7% ) は貯蓄率 ( 1.4% ) を上回っています。

収益対市場: FAGRの収益 ( 14.7% ) Belgian市場 ( 19.8% ) よりも低い成長が予測されています。

高成長収益: FAGRの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: FAGRの収益 ( 7.1% ) Belgian市場 ( 7.4% ) よりも低い成長が予測されています。

高い収益成長: FAGRの収益 ( 7.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: FAGRの自己資本利益率は、3年後には低くなると予測されています ( 16.5 %)。

Fagron 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Fagron NV Reaffirms Earnings Guidance for the Full Year 2024

Fagron Provides Earnings Guidance for the Fiscal Year 2024

Fagron NV Provides Earnings Guidance for the Full Year 2024

Fagron Nv Provides Earnings Guidance for 2023

Fagron NV (EBR:FAGR) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Price target decreased to €20.33

Recent updates

Fagron NV (ENXTBR:FAGR) ) signed an agreement to acquire Euro OTC Pharma GmbH.

Fagron NV Reaffirms Earnings Guidance for the Full Year 2024

Risks To Shareholder Returns Are Elevated At These Prices For Fagron NV (EBR:FAGR)

First half 2024 earnings released: EPS: €0.55 (vs €0.45 in 1H 2023)

Dividend of €0.21 announced

Fagron NV Approves Dividend for the Year 2023, Payable on 23 May 2024

Fagron NV's (EBR:FAGR) CEO Will Probably Find It Hard To See A Huge Raise This Year

The Returns At Fagron (EBR:FAGR) Aren't Growing

Fagron Provides Earnings Guidance for the Fiscal Year 2024

Is Fagron (EBR:FAGR) A Risky Investment?

Earnings Tell The Story For Fagron NV (EBR:FAGR)

Full year 2023 earnings: EPS exceeds analyst expectations

Fagron NV, Annual General Meeting, May 13, 2024

Fagron NV Provides Earnings Guidance for the Full Year 2024

Fagron Nv Provides Earnings Guidance for 2023

Fagron NV to Report First Half, 2024 Results on Aug 01, 2024

Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly

First half 2023 earnings released: EPS: €0.45 (vs €0.48 in 1H 2022)

Be Wary Of Fagron (EBR:FAGR) And Its Returns On Capital

Fagron (EBR:FAGR) Has Announced That It Will Be Increasing Its Dividend To €0.175

Fagron Nv Announces Board Changes

An Intrinsic Calculation For Fagron NV (EBR:FAGR) Suggests It's 30% Undervalued

Is Fagron (EBR:FAGR) A Risky Investment?

Full year 2022 earnings: EPS misses analyst expectations

Full year 2022 earnings released: EPS: €0.96 (vs €0.84 in FY 2021)

Fagron Nv Proposes Dividend

Fagron NV to Report Fiscal Year 2022 Results on Feb 09, 2023

Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly

High number of new directors

First half 2022 earnings released

Fagron NV Announces Management Changes

Fagron NV (ENXTBR:FAGR) acquired 503B Outsourcing Facility in Boston from Fresenius Kabi USA, LLC.

Return Trends At Fagron (EBR:FAGR) Aren't Appealing

High number of new directors

Fagron (EBR:FAGR) Is Paying Out A Larger Dividend Than Last Year

Fagron NV Approves Dividend for the Fiscal Year 2021, Payable on 18 May 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Is Fagron (EBR:FAGR) Using Too Much Debt?

Fagron NV Proposes Dividend for the Fiscal Year of 2021

Fagron NV to Report Fiscal Year 2021 Final Results on Apr 08, 2022

Slowing Rates Of Return At Fagron (EBR:FAGR) Leave Little Room For Excitement

Now 20% undervalued

Full year 2021 earnings: EPS exceeds analyst expectations

Fagron Nv Proposes Dividend

Signet Healthcare Partners, Bionpharma Inc. and GMS Capital Partners LLC acquired 80% stake in Contract Manufacturing Business Unit of Fagron NV for $10 million.

Fagron (EBR:FAGR) Has A Pretty Healthy Balance Sheet

Fagron (EBR:FAGR) Is Experiencing Growth In Returns On Capital

Are Investors Undervaluing Fagron NV (EBR:FAGR) By 45%?

Fagron NV (EBR:FAGR) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

First half 2021 earnings released: EPS €0.37 (vs €0.43 in 1H 2020)

Is Fagron (EBR:FAGR) A Risky Investment?

Price target decreased to €20.33

Fagron NV (EBR:FAGR) Shares Could Be 49% Below Their Intrinsic Value Estimate

The Returns At Fagron (EBR:FAGR) Aren't Growing

Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly

Is Fagron NV (EBR:FAGR) A Smart Choice For Dividend Investors?

The Returns At Fagron (EBR:FAGR) Provide Us With Signs Of What's To Come

Is Fagron NV (EBR:FAGR) Popular Amongst Institutions?

How Much Does Fagron's (EBR:FAGR) CEO Make?

Are Investors Undervaluing Fagron NV (EBR:FAGR) By 25%?

Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly

Fagron NV to Report Fiscal Year 2020 Results on Feb 11, 2021

Should You Be Excited About Fagron NV's (EBR:FAGR) 26% Return On Equity?

Fagron NV (ENXTBR:FAGR) acquired Pharma Tamar.

New 90-day high: €21.64

New 90-day high - €19.79

Is Fagron (EBR:FAGR) Using Too Much Debt?

New 90-day low - €18.51

Why Fagron NV (EBR:FAGR) Looks Like A Quality Company